| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/11/2002 | EP1263766A1 Adam polynucleotides, polypeptides, and antibodies |
| 12/11/2002 | EP1263762A1 Anti-infective ectatm |
| 12/11/2002 | EP1263761A2 Compounds for pdt |
| 12/11/2002 | EP1263760A1 Novel compounds |
| 12/11/2002 | EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 12/11/2002 | EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 12/11/2002 | EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 12/11/2002 | EP1263742A1 Oxazolidinone thioamides with piperazine amide substituents |
| 12/11/2002 | EP1263732A1 Corticotropin releasing factor antagonists |
| 12/11/2002 | EP1263730A1 Amine derivatives for the treatment of apoptosis |
| 12/11/2002 | EP1263725A1 Novel compounds |
| 12/11/2002 | EP1263724A1 Novel compounds |
| 12/11/2002 | EP1263718A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263715A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263482A1 Apparatus and method of treatment of wounds, burns and immune system disorders |
| 12/11/2002 | EP1263471A2 Antimicrobial compounds and formulations |
| 12/11/2002 | EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 12/11/2002 | EP1263467A1 Improved paste formulations |
| 12/11/2002 | EP1263465A2 Photodynamic cellular and acellular organism eradication using a photosensitive material and surfactant |
| 12/11/2002 | EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 12/11/2002 | EP1263461A1 Adenovirus formulations |
| 12/11/2002 | EP1263457A2 Hiv immune adjuvant therapy |
| 12/11/2002 | EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 12/11/2002 | EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 12/11/2002 | EP1263429A1 Antiviral therapy |
| 12/11/2002 | EP1263427A1 Il-8 receptor antagonists |
| 12/11/2002 | EP1263426A1 Preparations for the non-traumatic excision of a nail |
| 12/11/2002 | EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 12/11/2002 | EP1263410A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 12/11/2002 | EP1263409A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 12/11/2002 | EP1175149B1 Disinfecting composition based on h2o2, acids and metal ions |
| 12/11/2002 | EP1140986B1 Pseudopeptide, synthesis method, reagent and applications |
| 12/11/2002 | EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 12/11/2002 | EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions |
| 12/11/2002 | EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors |
| 12/11/2002 | EP0835131B1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86 |
| 12/11/2002 | EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases |
| 12/11/2002 | EP0788511B1 Cyclic hexapeptides having antibiotic activity |
| 12/11/2002 | EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 12/11/2002 | EP0722446B1 Distamycin a analogues as antitumour or antiviral agents |
| 12/11/2002 | EP0713397B1 Vaccine containing live virus |
| 12/11/2002 | EP0591431B1 Hepatitis c virus (hcv) polypeptides |
| 12/11/2002 | CN1384884A Herpes virus vectors for dendritic cells |
| 12/11/2002 | CN1384883A Production of recombinant respiratory syncytical viruses expressing immune modulatory molecules |
| 12/11/2002 | CN1384877A Rescue of mumps virus from cDNA |
| 12/11/2002 | CN1384876A Modular transport systems for molecular substances and production and use thereof |
| 12/11/2002 | CN1384839A Redox reversible HCV proteins with native-like conformation |
| 12/11/2002 | CN1384838A Macrolide antinfective agents |
| 12/11/2002 | CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys |
| 12/11/2002 | CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 12/11/2002 | CN1384745A Pharmaceutical compositions containing fluoroquinolone antibiotic drug and xanthan gum |
| 12/11/2002 | CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors |
| 12/11/2002 | CN1384733A Dry powder compositions having improved dispersivity |
| 12/11/2002 | CN1384119A Composite yolk antibody for resisting fowl's viral blight and its prepn and application |
| 12/11/2002 | CN1384116A New-type alpha-interferon |
| 12/11/2002 | CN1384108A Prepn process of 4''-substituted 9-deoxy-9A aza-9A homoerythromycin derivative |
| 12/11/2002 | CN1383884A Medicine ointment for eliminating tinea manuum |
| 12/11/2002 | CN1383881A Gansukang capsule |
| 12/11/2002 | CN1383879A Plaster using paper as carrier for treating beriberi |
| 12/11/2002 | CN1383876A Chinese medicine for treating hepatitis B |
| 12/11/2002 | CN1383854A Syphilis treating Chinese medicine |
| 12/11/2002 | CN1383850A Ganweikang tablet and its prepn |
| 12/11/2002 | CN1383845A Wide-spectrum antiseptic medicine research technical scheme |
| 12/11/2002 | CN1383828A Blood-type grasserie preventing and treating medicine for silkworm and its prepn |
| 12/11/2002 | CN1383827A Prepn of antiviral N-9 substituted guanine medicine powder for injection |
| 12/11/2002 | CN1383826A Silkworm disease preventing and treating medicine and its prepn |
| 12/11/2002 | CN1383822A Tefu medicine liquid and its prepn |
| 12/11/2002 | CN1095675C Medicinal plaster for curing wind-cold-dampness pathogen and traumatic injury |
| 12/11/2002 | CN1095664C Thiadizoles compound and drug compositions and use thereof |
| 12/11/2002 | CN1095662C Injection formulations of avermectins or milbemycins based on castor oil, prep. thereof and related use of castor oil |
| 12/11/2002 | CN1095659C Bath lotion series with anti-inflammatory, antipruritic and antibiotic functions |
| 12/11/2002 | CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum |
| 12/10/2002 | US6493637 Coincidence detection method, products and apparatus |
| 12/10/2002 | US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis. |
| 12/10/2002 | US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems |
| 12/10/2002 | US6492425 Inhibitors of transcription factor-NF-κB |
| 12/10/2002 | US6492423 Hepatitis c and b viricides |
| 12/10/2002 | US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 12/10/2002 | US6492410 Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer |
| 12/10/2002 | US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof |
| 12/10/2002 | US6492391 Treating bacterial infection |
| 12/10/2002 | US6492383 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| 12/10/2002 | US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 12/10/2002 | US6492376 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 12/10/2002 | US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 12/10/2002 | US6492343 Porcine adenovirus type 3 genome |
| 12/10/2002 | US6492342 Hygromycin A prodrugs |
| 12/10/2002 | US6492165 Retrovirus isolated from humans |
| 12/10/2002 | US6492148 A method for the preparation of an infectious ibdv mutant which will replicate in cef cell culture, comprising: separately preparing a dna construct comprising cdna of genome segments a and b of an ibdv which is not capable of |
| 12/10/2002 | US6492145 Vaccine against mycobacterial infections |
| 12/10/2002 | US6492104 EIA test using nondenatured HIV antigen for early detection of HIV infection |
| 12/10/2002 | US6491933 Personal care articles comprising hotmelt compositions |
| 12/10/2002 | US6491915 Anti-CCR2 antibodies and methods of use therefor |
| 12/10/2002 | US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells |
| 12/10/2002 | US6491893 Compounds for targeting and imaging infection and inflammation |
| 12/10/2002 | CA2208792C Substituted indazole derivatives |
| 12/10/2002 | CA2109934C Substituted indoles as anti-aids pharmaceuticals |
| 12/10/2002 | CA2086925C New salts derived from dialkylaminoalkysulphonyl-26 pristinamycin iib |
| 12/10/2002 | CA2047290C Recombinant marek's disease virus |
| 12/08/2002 | CA2817619A1 Methods of administering anti-tnf.alpha. antibodies |